Hematologic complications of rheumatic diseaseRICHERT-BOE, K. E.Hematology/oncology clinics of North America. 1987, Vol 1, Num 2, pp 301-320, issn 0889-8588Article

³²P AND ACUTE LEUKEMIA: DEVELOPMENT OF LEUKEMIA IN A PATIENT WITH HEMOGLOBIN YAKIMABAGBY GC JR; RICHERT BOE K; KOLER RD et al.1978; BLOOD; USA; DA. 1978; VOL. 52; NO 2; PP. 350-354; BIBL. 20 REF.Article

THERAPY-RELATED PRELEUKEMIC SYNDROMEANDERSON RL; BAGBY GC JR; RICHERT BOE K et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 7; PP. 1867-1871; BIBL. 16 REF.Article

Screening for cancers of the cervix and breastRICHERT-BOE, K. E; HUMPHREY, L. L.Archives of internal medicine (1960). 1992, Vol 152, Num 12, pp 2405-2411, issn 0003-9926Article

Screening for cancers of the lung and colonRICHERT-BOE, K. E; HUMPHREY, L. L.Archives of internal medicine (1960). 1992, Vol 152, Num 12, pp 2398-2404, issn 0003-9926Article

In vitro hematopoiesis in myelodysplasia liquid and soft-gel culture studiesRICHERT-BOE, K. E; BAGBY, C. C.Hematology/oncology clinics of North America. 1992, Vol 6, Num 3, pp 543-556, issn 0889-8588Article

Heterogeneity of cancer surveillance practices among medical oncologists in Washington and OregonRICHERT-BOE, K. E.Cancer. 1995, Vol 75, Num 10, pp 2605-2612, issn 0008-543XConference Paper

Phase II study of edatrexate in advanced head and neck cancer : a Southwest Oncology Group studyKUEBLER, J. P; BENEDETTI, J; SCHULLER, D. E et al.Investigational new drugs. 1994, Vol 12, Num 4, pp 341-344, issn 0167-6997Article